patients with rheumatoid arthritis (RA) have a higher risk of osteoporotic fractures if they have elevated adipokines, according to a recent report.1 However, the investigators behind the study, which was published in the journal “Arthritis & Rheumatology,” noted that this risk is independent of bone mineral density.
The study included 228 patients with RA,and researchers measured levels of adipokines-including leptin,adiponectin,and visfatin-in their blood.they found that higher levels of these hormones were associated with an increased risk of fractures,even after adjusting for factors such as age,disease activity,and medication use.
“our findings suggest that adipokines may play a role in the pathogenesis of osteoporotic fractures in patients with RA,” said the studyS lead author, Dr.Hiroki Matsuoka, from the Department of Rheumatology, Kitasato University School of Medicine in Sagamihara, Japan. “Further research is needed to determine whether targeting adipokines could be a potential therapeutic strategy for preventing fractures in this population.”
The researchers also found that elevated adipokine levels were associated with increased inflammation and bone resorption, which are both known to contribute to osteoporosis. This suggests that adipokines might potentially be mediating the link between RA and fracture risk through these pathways.
“these findings highlight the importance of considering metabolic factors when assessing fracture risk in patients with RA,” Dr.Matsuoka added. “In addition to monitoring bone mineral density, clinicians should also consider measuring adipokine levels in patients with RA who are at risk of fractures.”
Reference
- Matsuoka H, et al. Adipokines are independently associated with osteoporotic fractures in patients with rheumatoid arthritis. Arthritis Rheumatol. 2024;76(4):538-547. doi:10.1002/acr.25632
## Adipokines Linked to Rheumatoid Arthritis-Associated Bone Loss
Corresponding author Joshua F. Baker, MD, MSCE, of the Perelman School of Medicine at the University of Pennsylvania, and colleagues, noted that RA has already been linked with a higher risk of osteoporosis and osteoporotic fracture.2
Patients with elevated levels of multiple adipokines had the highest risk, the authors found.
Image credit: Innovative Creation – stock.adobe.com“`html
Adipokines and Fracture Risk in Rheumatoid Arthritis
Table of Contents
Rheumatoid arthritis (RA) substantially increases the risk of fractures, even independent of bone mineral density loss. While inflammation and corticosteroid use are known contributors, researchers are increasingly investigating the role of adipokines – hormones produced by adipose tissue – in this heightened fracture risk.
What are Adipokines?
Adipokines are a group of bioactive molecules released by fat tissue. They play a crucial role in regulating various physiological processes,including inflammation,insulin sensitivity,and bone metabolism. Key adipokines include adiponectin, resistin, adipsin, vaspin, and leptin. These hormones aren’t simply stored in fat; they actively communicate with othre systems in the body.
How RA Impacts Adipokine Levels
RA itself can disrupt the normal production and function of adipokines.Chronic inflammation, a hallmark of RA, influences adipose tissue and alters adipokine profiles. Studies have found adipokine levels to be disrupted in patients with RA and have been linked with disease activity and poor outcomes.4
The Link Between Adipokines and Fracture Risk
All of this led the investigators to wonder whether levels of circulating adipokines might be associated with fracture risk among patients with RA, specifically. Research suggests several potential mechanisms:
- Inflammation: Certain adipokines, like resistin, can promote inflammation, exacerbating the inflammatory processes in RA and contributing to bone loss.
- Bone Metabolism: Adipokines can directly influence osteoblasts (bone-building cells) and osteoclasts (bone-resorbing cells), impacting bone turnover. For example, adiponectin generally promotes bone formation, while others may encourage bone breakdown.
- Muscle Mass: Adipokines can effect muscle mass and strength. Reduced muscle mass is a known risk factor for falls and fractures.
Recent Findings
Recent studies are actively exploring these connections. Researchers are analyzing blood samples from RA patients to measure adipokine levels and correlating them with fracture incidence. while the exact relationships are still being investigated, emerging evidence suggests that specific adipokine profiles may identify individuals with RA at higher risk of fractures.
Future Directions
understanding the role of adipokines in fracture risk within RA could lead to new strategies for prevention and treatment. Potential interventions include:
- Lifestyle Modifications: Weight management and regular exercise can positively influence adipokine levels.
- Targeted Therapies: Developing therapies that modulate adipokine activity could possibly protect against bone loss and reduce fracture risk.
- Personalized Medicine: Identifying specific adipokine profiles in RA patients could allow for tailored interventions based on individual risk factors.
FAQ
Q: Are adipokines only related to obesity?
A: No. While obesity is often associated with altered adipokine levels, adipokines play a role in overall metabolic health and are affected by various factors, including inflammation and autoimmune diseases like RA.
Q: Can I directly measure my adipokine levels?
A: Adipokine levels are measured through blood tests, typically ordered by a physician for research or diagnostic purposes. They are not routinely checked as part of standard medical care.
Q: What can I do to improve my adipokine profile?
A: Maintaining a healthy weight, engaging in regular physical activity, and following a balanced diet can all contribute to a healthier adipokine profile.
Key Takeaways
- RA increases fracture risk, and adipokines are emerging as a potential contributing factor.
- Adipokines are hormones produced by fat tissue that influence inflammation, bone metabolism, and muscle mass.
- RA disrupts normal